Market Overview

UPDATE: Morgan Stanley Reiterates On H&R Block Following Management Meeting

Related HRB
Markets Begin The Week On A Losing Note Ahead Of Earnings Kick-Off, Fed Minutes
EZchip Falls On Lowered Sales Forecast; Durata Therapeutics Shares Jump
Tax Season Lifts H&R Block Earnings (Fox Business)

In a report published Tuesday, Morgan Stanley analyst Thomas Allen reiterated an Overweight rating on H&R Block (NYSE: HRB), but removed the $38.00 price target.

In the report, Morgan Stanley noted, “New Affordable Care Act (ACA) tax forms could come out as soon as this week. We expect that unlike in MA where every filer has to submit a Schedule HC form to show they have health insurance, at the Federal level, compliance will be integrated into core forms (like 1040s). However, forms 8962 (subsidy reconciliation) and 8965 (penalty and exemption) will be complicated so could well create pricing opportunities (not included in our base case F15e EPS of $2.00).”

H&R Block closed on Monday at $33.52.

Latest Ratings for HRB

DateFirmActionFromTo
Aug 2014Credit SuisseMaintainsOutperform
Apr 2014Morgan StanleyMaintainsOverweight
Feb 2014Credit SuisseInitiates Coverage onOutperform

View More Analyst Ratings for HRB
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Thomas AllenAnalyst Color Price Target Analyst Ratings

 

Related Articles (HRB)

Around the Web, We're Loving...

Get Benzinga's Newsletters